Remove 2011 Remove Pharmaceuticals Remove Pharmacy
article thumbnail

Manitoba Judge’s Opinion Reveals Different Side of the CanadaDrugs Case

Policy Prescription

It’s important because this case was wrongly used as a pretext to oppose safe personal drug importation and international online pharmacies, which help Americans afford prescription drugs. clinics in 2011. Kris Thorkelson never pled guilty to selling counterfeit drugs. Kris Thorkelson never pled guilty to selling counterfeit drugs.

article thumbnail

CMS Finalizes Guidance on Medicare Part D Manufacturer Discount Program

FDA Law Blog: Biosimilars

As part of this change, the Coverage Gap Discount Program (CGDP), a program that has existed since 2011, will sunset on December 31, 2024, and be replaced by the Medicare Part D Manufacturer Discount Program (the “Discount Program”). state pharmaceutical assistance programs). 1395w-114c(b)(4)(B)(i).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Educating Patients about Generic Drugs: Strategies for Success

Drug Patent Watch

Generic drugs are pharmaceutical products that contain the same active ingredients as their brand-name counterparts. It’s always a good idea to compare prices at different pharmacies. ” Health Affairs, 2011. What Are Generic Drugs? FAQs Q: Are generic drugs always cheaper than brand-name medications? Shrank, W.H.,

Drugs 75
article thumbnail

The BFDs – The Ten Best Prescription Drug/Medical Device Decisions of 2023

Drug & Device Law

2023) (HHS cannot force pharmaceutical manufacturers to sell unlimited amounts of prescription drugs at a discount) ( here ). Thus, CEH turned on implied impossibility preemption, specifically an application of Mensing ( 2011+1 ) independence principle. Forest Pharmaceuticals, Inc. 4th 851 (6th Cir. denied , 144 S. 4th 696 (3d.

article thumbnail

Another RICOdiculous Decision

Drug & Device Law

We’ve discussed recently how a federal statute intended to allow suits against international terrorists has been misapplied as allowing suits against pharmaceutical companies. Takeda Pharmaceuticals Co. , Takeda Pharmaceutical Co. , 3d 1243 (9th Cir. 1 (highlights). 3d at 1247. 3d , 2023 WL 4191651 (C.D.

article thumbnail

NPP, DCC, And FDA-Regulated Medical Products

Drug & Device Law

2011), aff’d , 741 F.3d In that Fourth Circuit case we mentioned above , the court looked to Healy (which knocked out a Connecticut wholesale beer pricing law) and Pharmaceutical Research & Manufacturers of America v. See Gross v. Pfizer, Inc. , 2d 654, 659 (D. 3d 470 (4th Cir. Walsh , 538 U.S. 644 (2003), but not to Pike.

article thumbnail

Agree To Disagree – Don’t  Sue the Other Side of a Scientific Dispute into Silence

Drug & Device Law

Criticizing attempts to sue publishers of scientific content, here in 2011, and again, here in 2013. 4, 2022), which rejected a pharmaceutical trade libel claim against a peer-reviewed medical article and the journal that published it. at *2 (citing, inter alia , Virginia State Board of Pharmacy v. 2022 WL 336585 (D.